Owner/Developer: IOMICS Corporation
|Country:||United States of America|
IOMICS is a leading-edge analytics company dedicated to science and healthcare. FUSION STS™ is a cloud deployed analytics platform designed for systems toxicology and in silico screening. FUSION STS utilizes multiple high-quality chemical and omic data types and advanced machine learning technologies to explore and predict toxicity potential in your compounds. FUSION STS is a complete solution providing experimental data, biochemical knowledge, and automated model development in one integrated application. FUSION STS can even be live linked with chemical assays, production instrumentation, and environmental sensors for real-time analysis and process control. FUSION STS is redefining the future of green chemical design, accelerated drug development, and safer food production.
|Audience:||Scientists - Industry - Researchers|
|User access:||Fee-based access|
|Updating frequency:||Frequently updated|
|Relevance:||Replacement - Reduction|
|Purpose:||Toxicological and safety evaluation|
|Technology/Tools:||Non-testing methods (in silico)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!Please contact us by email if you have any questions.